...
机译:烟酰胺磷酰基转移酶抑制剂作为抗体药物缀合物的新有效载荷
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Novartis Institutes for BioMedical Research;
Antibody?drug conjugate (ADC); nicotinamide phosphoribosyltransferase (NAMPT); novel payload;
机译:烟酰胺磷酰基转移酶抑制剂作为抗体药物缀合物的新有效载荷
机译:抗体 - 药物缀合物与吡咯基KSP抑制剂作为有效载荷等级
机译:天然产物剪接抑制剂:一类新型的抗体-药物偶联物(ADC)有效负载
机译:对猴子研究中的抗体药物缀合物未缀合有效载荷的LC-MS / MS生物分析的抗药物 - 抗体的影响
机译:作为抗体 - 药物共轭有效载荷的表现为赤素酮的发展
机译:烟酰胺磷酸核糖基转移酶抑制剂抗体-药物结合的新型有效载荷
机译:IL3ARA靶向抗体 - 药物共轭湾-943具有Kinesin主轴蛋白抑制剂有效载荷显示血液学恶性肿瘤临床前模型的疗效